Over €1 million in funding for antimicrobial resistance research


Two research teams at Leiden University have secured over €1 million in funding through the NACTAR programme (Dutch Research Agenda) to explore innovative solutions to antimicrobial resistance (AMR).

Led by Prof. Gilles van Wezel, the first project focuses on unlocking hidden antibiotics from soil bacteria using advanced genome-editing tools. The second, led by Dr. Karina Xavier in collaboration with Wageningen University, investigates how gut microbes can be used to prevent infections by outcompeting harmful bacteria.

Both projects reflect the interdisciplinary strength of the Leiden Bio Science Park and aim to contribute to safer, more effective alternatives to traditional antibiotics.

“These projects show how our research ecosystem is driving solutions to critical global challenges,” said an LBSP spokesperson.

Read more on the Leiden University website.


  • SpectaCell raises €6 million to accelerate drug development

    For the Leiden Bio Science Park, it is great to see SpectaCell connecting its technology with the biotech ecosystem here in Leiden. SpectaCell will combine its technology development and cell analysis in Ghent with further validation and application within the…

  • LUMC opens dedicated CAR-T department

    Leiden University Medical Center (LUMC) has opened a dedicated department for CAR-T cell therapy, bringing care, research and expertise in this rapidly developing field together in one place. The new department, officially opened on 24 September, marks another step in…